ClinicalTrials.gov
ClinicalTrials.gov Menu

Is the Medium the Message?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03374865
Recruitment Status : Recruiting
First Posted : December 15, 2017
Last Update Posted : December 15, 2017
Sponsor:
Information provided by (Responsible Party):
Radboud University

Brief Summary:

Digital communication media like video‐interaction (cf. Skype) are increasingly being adopted in institutional environments like hospitals for physician‐patient interactions. We may expect that the use of a digital medium affects these interactions in various ways and on various levels. In video‐interaction, eye contact for example is impossible due to the position of the camera, which implies interactional behavior through gaze is impaired. This may influence who speaks when, if and how the participants avoid/ solve misunderstandings, etcetera. This project makes headway in our understanding of the impact of new communication media on the role of language‐in‐use as a rich semiotic system, specifically in institutional interaction. This type of contextualized research reveals which communicative aspects users consider important, how they manage their institutional relationship through them and how they go about solving communication problems.

The project compares the interaction of physicians and patients in video‐mediated consultations to their traditional, face‐to‐face counterparts on both the verbal and the nonverbal (gaze) level. The affordances of video‐consultations with relevance to institutional goals and identities are analyzed through a comparison with the interaction in face‐to‐face consultations. The approach used is Conversation Analysis, which involves finding patterns on both the verbal and non‐verbal level (in sequences, turn design, preference, etc.) in order to answer the question what goals and tasks the participants achieve and what dilemma's or problems they aim to solve in their talk. This study will provide insights in the limitations and advantages of both channels of communication. Best practices will be generated and outcomes of the analyses will be used to develop reco


Condition or disease Intervention/treatment
Video-mediated Consultation Face to Face Consultation Other: Facetalk Other: Face-to-face consultation

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Is the Medium the Message? A Study of the Affordances of Video-mediated Medical Consultations Compared to Traditional Consultations
Actual Study Start Date : June 1, 2017
Estimated Primary Completion Date : September 1, 2018
Estimated Study Completion Date : December 1, 2018

Group/Cohort Intervention/treatment
Video-mediated consultation
Consultations using Facetalk videocommunication software
Other: Facetalk
Area of interest: communication during Facetalk consultations

Face-to-face consultation
Traditional face-to-face consultations
Other: Face-to-face consultation
Area of interest: communication during face-to-face consultations




Primary Outcome Measures :
  1. Verbal communication [ Time Frame: 10 minutes ]

    Verbal communication. The main method is multimodal conversation analysis. Conversation analysis has a long tradition of research based on the rendition of talk and interaction in terms of written transcripts of the audible cues. The video‐mediated and face‐to‐face interactions will be compared. This means that phenomena observed in the video‐mediated consultations will be compared to equivalent actions and practices in the face‐to‐face consultations. Relevant phenomena are likely to be the opening of the conversation (checking the technology), the design of questions (use of more lexical tokens than deixis), particular gestures, specific repair sequences due to technical trouble etc.). The analysis will be descriptive.

    All talk will be transcribed according to CA conventions. Software like ELAN may be used for the synchronization of multiple video data and for the annotation of (fragments of) the video data.



Secondary Outcome Measures :
  1. Non-verbal communication [ Time Frame: 10 minutes ]
    Body language



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Discharged post-operative patients from a single tertiary medical center
Criteria

Inclusion Criteria:

  • Discharged post-operative patients
  • Follow up consultation for pathology results

Exclusion Criteria:

- Physical examination needed


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03374865


Contacts
Contact: Martijn Stommel 024 361 1111 Martijn.Stommel@radboudumc.nl

Locations
Netherlands
RadboudUMC Recruiting
Nijmegen, Netherlands
Contact: Martijn Stommel    024 361 1111      
Sponsors and Collaborators
Radboud University

Responsible Party: Radboud University
ClinicalTrials.gov Identifier: NCT03374865     History of Changes
Other Study ID Numbers: 2016-2822
First Posted: December 15, 2017    Key Record Dates
Last Update Posted: December 15, 2017
Last Verified: June 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No